Dexcom has obtained an FDA clearance for its basal insulin dosing optimizing program, designed for adults with Type 2 diabetes using its continuous glucose monitors. The company said its Smart Basal ...

The US FDA has cleared a new “basal insulin dose optimizer” function for the Dexcom G7 15-day continuous glucose monitor (CGM), which is set to launch separately on December 1, 2025. The “Smart Basal” ...

DexCom's growth rate has been accelerating for multiple quarters, and recently came in at around 22%. A rise in GLP-1 drugs has some investors concerned that DexCom's growth opportunities may be ...

The Carolina Panthers' undrafted wide receiver, Dan Chisenda, was called up from the practice squad this week. This move comes after many injuries to the wide receiver position, with rookie standout ...

A number of stocks jumped in the afternoon session after comments from a key Federal Reserve official bolstered hopes for an interest rate cut. New York Federal Reserve President John Williams stated ...

・Investors focused on Dexcom’s lower gross margin of 61.3%, down about 170 basis points year-over-year, despite record revenue and earnings. ・The company said elevated scrap and freight costs would ...

In the midst of his second NFL season, Terry McLaurin was waiting in line at a Chick-fil-A drive-thru when he got a call from Brian Hartline, his former receivers coach at Ohio State. Hartline wanted ...

earing the later part of the 2025 season, the San Francisco 49ers are still very much alive in the NFC playoff chase. Sitting at 7-4, the 49ers have found ways to win even though they have dealt with ...

San Francisco 49ers receiver Brandon Aiyuk has not yet played this season. Christian Petersen / Getty Images Fifteen months ago, wide receiver Brandon Aiyuk and the San Francisco 49ers ended a ...